Highest-materiality recent filing
Regis Q3 FY2026 net income $0.7M ($0.26 EPS); adjusted EPS $0.57, consolidated SSS +2.6%
Consolidated revenue $52.4M vs $57.0M (-8.1% YoY); operating income $5.7M vs $5.0M; net income $0.7M vs $0.3M.
Regis appoints large shareholder Bill Charters as independent director, effective April 24
William Charters appointed independent director effective April 24, 2026.
Regis appoints Susan Lintonsmith CEO, Jim Lain COO, Nancy Benacci Board Chair
Susan Lintonsmith named CEO effective March 16, 2026; she previously served as Board Chair.
Regis appoints Susan Lintonsmith as CEO, Jim Lain as COO, Andrew Alfano to board
Susan Lintonsmith named President and CEO effective March 16, 2026; base salary $650,000, annual target bonus 125% of base.
Regis Q2 revenue $57.1M (+22% YoY); Supercuts comps +2.0%; adj. EBITDA $8.0M
Consolidated revenue $57.1M, up $10.4M YoY, driven by Alline acquisition; company-owned salon revenue $19.2M.
Regis Q1 FY2026 revenue $59.0M; net income $1.4M vs loss; same-store sales +0.9%
Revenue rose $12.9M to $59.0M, driven by Alline acquisition; operating income improved to $5.9M from $2.1M.
Regis Corp shareholders elect all director nominees, approve all proposals at annual meeting
All five director nominees elected with ~637k votes for each; against votes ~80k.
Regis Q4 rev $60.4M, adj EBITDA $9.7M; releases $116.3M tax valuation allowance
Q4 consolidated revenue $60.4M (+$11M YoY); operating income $7.3M vs $4.6M.
CEO Matthew Doctor resigns effective June 30, 2025; remains part-time through Aug 31 at 50% base salary.
Revenue $57.0M (+15.9% YoY); net income $0.3M ($0.08 diluted EPS) vs net loss of $2.3M in prior-year Q3.
Regis files Alline financials; acquisition cost $24.6M with $15M new term loan
Regis acquired 100% of Alline (314 salons) for total consideration of $24.6M: $18.6M cash (net), $3.0M stock, up to $3.0M contingent earnout.
Regis Q2 FY2025: Net income $7.6M, adj. EPS $0.61 vs -$0.18; Alline acquisition adds $1.7M revenue
Consolidated revenue $46.7M, down 8.6% YoY; franchise rental income decline offset by Alline salon revenue.
Regis Corp adopts LT cash incentive plan based on adjusted EBITDA for FY2025-2027
CEO Applicable Percentage ~32%; other executive officers ~11% each of Aggregate Excess EBITDA.
Regis extends tax benefits preservation plan through Jan 2028
Amendment extends Plan expiration from Jan 29, 2025 to Jan 29, 2028.
Regis eliminates EVP/Chief Digital Officer role; John Davi to transition by March 31, 2025
John Davi's position as EVP and Chief Digital Officer eliminated effective January 31, 2025.
Regis appoints Susan Lintonsmith to Board of Directors effective Jan 15, 2025
Susan Lintonsmith appointed to Regis Board effective January 15, 2025.
Regis acquires Alline Salon Group for $22M; adds $83M revenue, $5.8M EBITDA
Initial consideration $22M ($19M cash + $3M stock); 140,552 shares issued; 1-yr lock-up.
Regis shareholders approve amended 2018 LTIP adding 225K shares; all director nominees elected
Shareholders approved Amended 2018 Long Term Incentive Plan (739,435 For) increasing share reserve by 225,000 shares and extending plan term.
Regis Q1 FY2025 net loss $0.9M; adjusted EPS rises to $0.93 from $0.71
Consolidated revenue $46.1M, down 13.7% from $53.4M; same-store sales -1.1% vs +1.8% prior year.
Regis reports Q4 net income $91.2M (EPS $38.10) vs loss a year ago; adjusted EBITDA up to $7.4M
Net income includes $94.6M gain on extinguishment of debt from June 2024 refinancing.
Regis appoints Jim Lain and Michael Ferranti to new brand operations roles
Jim Lain transitions from EVP/COO to EVP Brand Operations – Supercuts and Cost Cutters, effective Aug 16, 2024.
Regis Corp issues warrants for 407,542 shares at $7.00 in financing deal
Warrants to purchase up to 407,542 shares of common stock at $7.00 per share.
New senior secured credit facility: $35M Term Loan A, $70M Term Loan B, and $25M revolver, maturing June 24, 2029.
Regis sells 55.1% stake in EEG for $1, exits cosmetology school operations
Sold 55.1% ownership interest in EEG, Inc. for $1.00 cash; no further interest in cosmetology schools.
Regis Q3 fiscal 2024: operating income up to $4.1M, net loss widens slightly to $2.4M
Operating income of $4.1M improved $2.1M from $2.0M in Q3 fiscal 2023.
Regis Corp Q2 net income $1.0M vs loss; revenue down; strategic review ongoing
System-wide revenue $292.4M, down 3.6% YoY; same-store sales up 1.9%.
Regis adopts tax benefits preservation plan to protect $646M NOLs
As of Sep 30, 2023, Regis had ~$646M federal NOLs; plan aims to avoid Section 382 ownership change limit.
Regis Corporation to transfer stock listing from NYSE to Nasdaq on Jan 9, 2024
Common stock will be delisted from NYSE after market close on Jan 8, 2024.
Regis Corp receives NYSE delisting notice for failure to meet $50M equity or market cap standard
Notice received Dec 13, 2023 under Section 802.01B for insufficient stockholders' equity or 30-day avg market cap below $50M.
Regis implements 20-for-1 reverse stock split, reduces authorized shares to 5M
Reverse stock split effective Nov 29, 2023; every 20 shares combined into 1 share.
Regis Corp announces 1-for-20 reverse stock split to meet NYSE minimum bid price
Reverse split ratio of 1-for-20; effective market open on November 29, 2023.
Regis posts Q1 net income $1.2M (first positive in 5 years); launches strategic alternatives review
Net income from continuing operations of $1.2M ($0.03 diluted EPS) vs loss of $1.8M (-$0.04) YoY; first positive since fiscal 2018.
All eight director nominees elected with votes ranging from 15.9M to 17.7M in favor.
Regis receives NYSE delisting notice for share price below $1.00
NYSE notified Regis on Oct 4, 2023 that 30-day avg closing price was $0.92, below $1.00 minimum.
Regis Corp reports Q4 operating income of $3.6M; FY23 adjusted EBITDA $21.0M
Q4 net loss $4.8M ($0.10/sh) vs loss $42.6M ($0.93/sh) year ago; operating income $3.6M vs loss $1.3M.
Regis reports Q3 operating income of $2M, net loss narrows to $1.6M; same-store sales up 6%
System-wide revenue $299.3M (+$8.3M YoY); system-wide same-store sales +6.0%.
Regis Q2: operating income turns positive; net loss narrows to $2.4M
Operating income of $0.7M vs. loss of $0.5M a year ago; excluding non-cash charges was $4.5M.
Regis Corp posts first operating profit in 16 quarters; Q1 FY2023 adjusted EBITDA turns positive
Operating profit of $2.5M vs ($4.9M) loss; first positive operating profit since Sept 2018.
Regis shareholders elect all 7 directors, approve say-on-pay, ratify Grant Thornton
Each director nominee received >11.2M votes in favor; Lockie Andrews had 11,779,202 for, 214,276 against.
Regis reports Q4 revenue $66.1M, FY2022 adjusted EBITDA positive; debt extended to 2025
Q4 revenue $66.1M, down 32.3% YoY on salon exits; royalty revenue up 12.1%.
Converted $180M of existing $295M revolver to term loan; revolver reduced to $55M.
Regis receives NYSE delisting notice for low market cap ($40.7M) and share price ($0.89)
30-day average market cap of $40.7M and stockholders' equity of $11.1M as of March 31, 2022, both below $50M.
Regis to sell Opensalon Pro to Zenoti for up to $39M; Zenoti becomes sole tech platform
Total cash consideration up to $39M: $20M at closing (with $4M escrow and $5.2M holdback) plus $19M contingent on salon migration to Zenoti.
Regis Q3 revenue $64.7M, down 35%; net loss $27.9M; adjusted EBITDA loss narrows to $0.3M
Revenue $64.7M, down 35.4% YoY; system-wide same-store sales +8.6% vs -20.7% prior year.
Regis appoints Matthew Doctor as permanent President and CEO, effective May 5, 2022
Matthew Doctor, 35, appointed President & CEO and director; had been interim CEO since Dec 2021.
Regis Q2 FY2022 net loss narrows to $4.9M; revenue down 32.7% on salon exits
Revenue $70.3M vs $104.3M YoY, down 32.7% due to exiting loss-making company-owned salons.
Regis CEO Felipe Athayde resigns; Matt Doctor named Interim CEO
Felipe Athayde resigns as President and CEO, effective March 19, 2022; remains on Board until then.
Director Daniel G. Beltzman resigns from Regis board effective Nov 14, 2021
Daniel G. Beltzman resigned as a member of the Board of Directors, effective November 14, 2021.
Regis Q1 net loss narrows to $10.4M ($0.28/share); same-store sales up 23.2%
Consolidated revenue fell 30.2% to $77.8M as company exited unprofitable company-owned salons.
Regis shareholders elect all eight director nominees and approve say-on-pay at 2021 annual meeting
All eight director nominees elected; Lockie Andrews received 25.7M for, 68.5K against.
On June 20, 2025, Matthew Doctor, the President and Chief Executive Officer and a member of the Board of Directors (the “Board”) of Regis Corporation (the “Company”) notified the Board that he would resign his positions, effective June 30, 2025.
the Board appointed Jim Lain, the Company’s Executive Vice President, Brand Operations - Supercuts and Cost Cutters, to serve as Interim President and Chief Executive Officer, effective July 1, 2025
the position held by John Davi, the Company’s Executive Vice President and Chief Digital Officer, will be eliminated effective January 31, 2025
On January 10, 2025, the Board of Directors of Regis Corporation (the “Company”) appointed Ms. Susan Lintonsmith to the Board of Directors, effective January 15, 2025.
Regis Corporation (the “Company”) announced the appointment of Jim Lain, who previously served as the Company’s Executive Vice President, Chief Operating Officer, to the position of Executive Vice President, Brand Operations – Supercuts and Cost Cutters, effective August 16, 2024.
At the same time, Michael Ferranti, who previously served as the Company’s Executive Vice President, Chief People Officer, was appointed to the position of Executive Vice President, Brand Operations – SmartStyle, First Choice Haircutters, Roosters, and Portfolio Brands, effective August 16, 2024.
On May 2, 2023, the Board of Directors of Regis Corporation (the "Company") appointed Ms. Nancy Benacci to the Board of Directors of the Company, effective May 1, 2023.
On May 5, 2022, Regis Corporation (the "Company") announced Matthew Doctor as the Company's President and Chief Executive Officer (CEO) and will be appointed as a director on the Company's Board of Directors (the "Board") effective May 5, 2022 ("Start Date").
On May 5, 2022, Regis Corporation (the "Company") announced Matthew Doctor as the Company's President and Chief Executive Officer (CEO) and will be appointed as a director on the Company's Board of Directors (the "Board") effective May 5, 2022 ("Start Date").
On December 19, 2021, Felipe A. Athayde, the President and Chief Executive Officer and a member of the Board of Directors (the "Board") of Regis Corporation (the "Company") notified the Board that he would resign his positions and his employment effective March 19, 2022.
the Board appointed Matthew Doctor, the Company's Executive Vice President and Chief Strategy Officer, to serve as Interim Chief Executive Officer effective December 23, 2021
the Board appointed Jim Lain, the Company's President, Franchise Operations, who functions as the Company's principal operating officer, to the position of Chief Operating Officer of the Company, also effective December 23, 2021
Max materiality 0.85 · Median 0.65 · Most common event earnings